» Articles » PMID: 26667886

Global Cancer Incidence and Mortality Rates and Trends--An Update

Overview
Date 2015 Dec 16
PMID 26667886
Citations 1582
Authors
Affiliations
Soon will be listed here.
Abstract

There are limited published data on recent cancer incidence and mortality trends worldwide. We used the International Agency for Research on Cancer's CANCERMondial clearinghouse to present age-standardized cancer incidence and death rates for 2003-2007. We also present trends in incidence through 2007 and mortality through 2012 for select countries from five continents. High-income countries (HIC) continue to have the highest incidence rates for all sites, as well as for lung, colorectal, breast, and prostate cancer, although some low- and middle-income countries (LMIC) now count among those with the highest rates. Mortality rates from these cancers are declining in many HICs while they are increasing in LMICs. LMICs have the highest rates of stomach, liver, esophageal, and cervical cancer. Although rates remain high in HICs, they are plateauing or decreasing for the most common cancers due to decreases in known risk factors, screening and early detection, and improved treatment (mortality only). In contrast, rates in several LMICs are increasing for these cancers due to increases in smoking, excess body weight, and physical inactivity. LMICs also have a disproportionate burden of infection-related cancers. Applied cancer control measures are needed to reduce rates in HICs and arrest the growing burden in LMICs.

Citing Articles

Assessing the performance of QLQ-C30 in predicting all-cause mortality in community cancer patients.

Zhao J, Wang Y, Huang W, Xu R, Yang X, Wang P BMC Cancer. 2025; 25(1):421.

PMID: 40055624 PMC: 11889892. DOI: 10.1186/s12885-025-13624-z.


Hallmarks of artificial intelligence contributions to precision oncology.

Chang T, Park S, Schaffer A, Jiang P, Ruppin E Nat Cancer. 2025; .

PMID: 40055572 DOI: 10.1038/s43018-025-00917-2.


Unveiling the oncogenic role of SLC25A13: a multi-omics pan-cancer analysis reveals its impact on glioma progression.

Wu W, Liu S, Ren H, Rao Y, Nie J, Wei K Cancer Cell Int. 2025; 25(1):76.

PMID: 40033307 PMC: 11874833. DOI: 10.1186/s12935-025-03696-z.


The Relevance of Sex and Age as Non-Modifiable Risk Factors in Relation to Clinical-Pathological Parameters in Colorectal Cancer.

Barna R, Dema A, Jurescu A, Vaduva A, Lazureanu D, Vita O Life (Basel). 2025; 15(2).

PMID: 40003565 PMC: 11856218. DOI: 10.3390/life15020156.


Pan-cancer analysis identifies ADAM12 as a prognostic biomarker and indicator of immune infiltration in glioma.

Lv P, Zhang Y, Wu W, Jiang X, Xiang W Sci Rep. 2025; 15(1):6314.

PMID: 39984619 PMC: 11845722. DOI: 10.1038/s41598-025-90121-0.